Combined Treatment with Epimedium koreanum Nakai Extract and Gefitinib Overcomes Drug Resistance Caused by T790M Mutation in Non-Small Cell Lung Cancer Cells

Author： Song Jie   Zhong Rongling   Huang Houcai   Zhang Zhenhai   Ding Dongmei   Yan Hongmei   Sun E   Jia Xiaobin  

Publisher： Routledge Ltd

ISSN： 0163-5581

Source： Nutrition and Cancer, Vol.66, Iss.4, 2014-05, pp. : 682-689

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Combined gefitinib and pemetrexed overcome the acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer

By        

Molecular Medicine Reports, Vol. 10, Iss. 2, 2014-01 ,pp. : 931-938

Spandidos Publications

Access to resources Recommend Favorite

The impact and role of EGFR gene mutation on non-small cell lung cancer

By Toyooka Shinichi   Soh Junichi   Shigematsu Hisayuki   Aoe Motoi   Date Hiroshi  

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 7, 2006-11 ,pp. : 25-31

Springer Publishing Company

Access to resources Recommend Favorite

The impact and role of EGFR gene mutation on non-small cell lung cancer

By Toyooka Shinichi   Soh Junichi   Shigematsu Hisayuki   Aoe Motoi   Date Hiroshi  

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 1, 2006-11 ,pp. : 25-31

Springer Publishing Company

Access to resources Recommend Favorite

Gefitinib in combination with prednisolone to avoid interstitial lung disease during non-small cell lung cancer treatment: A case report

By                  

Oncology Letters, Vol. 5, Iss. 5, 2013-01 ,pp. : 1599-1600

Spandidos Publications

Access to resources Recommend Favorite

A peptide antigen derived from EGFR T790M is immunogenic in nonsmall cell lung cancer

By  

International Journal of Oncology, Vol. 46, Iss. 2, 2015-01 ,pp. : 497-504

Spandidos Publications

Access to resources Recommend Favorite